Concepedia

Gregory R. Ott

GR

Statistics

Publications

28

Citations

1.2K

H-Index

22

Active since

1994

Affiliations

Teva Pharmaceuticals (United States)(Current)

Bristol-Myers Squibb (United States)

Monell Chemical Senses Center

Thomas Jefferson University

University of Pennsylvania

Gregory R. Ott is an author at Teva Pharmaceuticals (United States) specializing in medicinal chemistry, drug discovery, and pharmacology.

Publications per year

1994–2020

28

Publications

28

Total Synthesis of (−)-Macrolactin A

Amos B. Smith, Gregory R. Ott · Journal of the American Chemical Society · 1996 · 112 citations

, , +7

Total Syntheses of (−)-Macrolactin A, (+)-Macrolactin E, and (−)-Macrolactinic Acid:  An Exercise in Stille Cross-Coupling Chemistry

Amos B. Smith, Gregory R. Ott · Journal of the American Chemical Society · 1998 · 100 citations

, , +15

Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)

Gregory R. Ott, Mangeng Cheng, Keith S. Learn et al. · Journal of Medicinal Chemistry · 2016 · 90 citations · Full text

, , +17

Multigram Synthesis of the C29−C51 Subunit and Completion of the Total Synthesis of Altohyrtin C (Spongistatin 2)

Clayton H. Heathcock, Mark McLaughlin, Jesús R. Medina et al. · Journal of the American Chemical Society · 2003 · 83 citations

, , +15

Induction of heat-shock gene expression in postischemic pig liver depends on superoxide generation

Luke O. Schoeniger, Kenneth A. Andreoni, Gregory R. Ott et al. · Gastroenterology · 1994 · 75 citations

, , +17

1–5 of 28